Keyphrases
Interleukin-2
100%
DNA Vaccine
100%
MBT-2
100%
Her2neu
100%
Tumor Immunity
100%
Therapeutic Vaccine
100%
Gene-modified
100%
Granulocyte Colony-stimulating Factor (G-CSF)
62%
Interleukin-4 (IL-4)
37%
Therapeutic Efficacy
25%
Tumor
12%
Tumor Cells
12%
Western Blotting
12%
Irradiation
12%
Immunohistochemical Analysis
12%
Antitumor Effect
12%
C3H Mice
12%
Bladder Cancer Cells
12%
Therapeutic Effect
12%
Tumor Mass
12%
Tumor Formation
12%
Tumor Antigen
12%
Lymphoid Cells
12%
Protective Effect
12%
CD4+
12%
Additive Effect
12%
Expression Vector
12%
Syngeneic
12%
Tumor DNA
12%
Tumor-infiltrating
12%
Immune Memory
12%
Co-injection
12%
No Additives
12%
CD4+ T Lymphocytes
12%
Immunology and Microbiology
HER2/neu
100%
Interleukin 2
100%
Tumor Vaccine
100%
DNA Immunization
100%
Granulocyte Macrophage Colony-Stimulating Factor
62%
Interleukin 4
37%
Cytokine
25%
CD4
12%
Cancer Cell
12%
Western Blot
12%
Tumor Cell
12%
Tumor Antigen
12%
Innate Lymphoid Cell
12%
Expression Vector
12%
Syngenic
12%
C3H Mouse
12%
Immunological Memory
12%
CD4+ T Lymphocyte
12%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 2
100%
Tumor Vaccine
100%
DNA Immunization
100%
Granulocyte Macrophage Colony Stimulating Factor
62%
Neoplasm
50%
Interleukin 4
37%
Cytokine
25%
Combination Therapy
25%
Western Blot
12%
Carcinogenesis
12%
C3H Mouse
12%
Bladder Cancer
12%
Therapeutic Effect
12%
Tumor Antigen
12%